BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36661506)

  • 1. In Vitro Evidence of Differential Immunoregulatory Response between MDA-MB-231 and BT-474 Breast Cancer Cells Induced by Bone Marrow-Derived Mesenchymal Stromal Cells Conditioned Medium.
    Arenas-Luna VM; Montesinos JJ; Cortés-Morales VA; Navarro-Betancourt JR; Peralta-Ildefonso J; Cisneros B; Hernández-Gutiérrez S
    Curr Issues Mol Biol; 2022 Dec; 45(1):268-285. PubMed ID: 36661506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
    Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
    Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cell-conditioned medium promotes MDA-MB-231 cell migration and inhibits A549 cell migration by regulating insulin receptor and human epidermal growth factor receptor 3 phosphorylation.
    Li P; Zhou H; Di G; Liu J; Liu Y; Wang Z; Sun Y; Duan H; Sun J
    Oncol Lett; 2017 Mar; 13(3):1581-1586. PubMed ID: 28454294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma.
    Zhou S; Cecere R; Philip A
    Oncotarget; 2017 Nov; 8(56):95632-95647. PubMed ID: 29221155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunomodulatory effects of mesenchymal stem cells derived from the bone marrow in acute leukemia patients].
    Zhao ZG; Sun L; Wang XF; Zhang YZ; Yu Y; Yang HL; Zou P
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):105-9. PubMed ID: 21575477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer cells and bone marrow mesenchymal stromal cells: a regulated modulation of the breast tumor in the context of immune response.
    Najar M; Fayyad-Kazan H; Faour WH; Badran B; Journe F; Lagneaux L
    Inflamm Res; 2017 Feb; 66(2):129-139. PubMed ID: 27783097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors.
    Zhang T; Lee YW; Rui YF; Cheng TY; Jiang XH; Li G
    Stem Cell Res Ther; 2013 Jun; 4(3):70. PubMed ID: 23763837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metformin on human bone-derived mesenchymal stromal cell-breast cancer cell line interactions.
    Teufelsbauer M; Lang C; Plangger A; Rath B; Moser D; Staud C; Radtke C; Neumayer C; Hamilton G
    Med Oncol; 2022 Feb; 39(5):54. PubMed ID: 35150338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymoquinone-treated mouse mesenchymal stem cells-derived conditioned medium inhibits human breast cancer cells in vitro.
    Hajmomeni P; Sisakhtnezhad S; Bidmeshkipour A
    Chem Biol Interact; 2023 Jan; 369():110283. PubMed ID: 36450322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production.
    Escobar P; Bouclier C; Serret J; Bièche I; Brigitte M; Caicedo A; Sanchez E; Vacher S; Vignais ML; Bourin P; Geneviève D; Molina F; Jorgensen C; Lazennec G
    Oncotarget; 2015 Oct; 6(30):29034-47. PubMed ID: 26362269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Microenvironment Changing through Application of MicroRNA-34a Related Mesenchymal Stem Cells Conditioned Medium: Modulation of Breast Cancer Cells toward Non-aggressive Behavior.
    Bahman Soufiani K; Pourfathollah AA; Nikougoftar Zarif M; Arefian E
    Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):221-232. PubMed ID: 33904680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-B1-over-expressed adipose stem cells-derived secretome exhibits CD44 suppressor and anti-cancer properties via antagonistic effects against SMAD4 in breast cancer cells.
    Salkin H; Yay A; Gokdemir NS; Gönen ZB; Özdamar S; Yakan B
    Am J Stem Cells; 2022; 11(5):64-78. PubMed ID: 36660741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria.
    Fayyad-Kazan H; Faour WH; Badran B; Lagneaux L; Najar M
    Inflamm Res; 2016 Jun; 65(6):501-10. PubMed ID: 26956767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunosuppressive effects of fetal bone marrow derived mesenchymal stem cells on in vitro proliferation of adult peripheral lymphocyte and expression of immune-related factors].
    Li F; Lyu J; Duan Y; Sun Y; Li D; Wang Y; Hu X; Xiao D
    Zhonghua Xue Ye Xue Za Zhi; 2014 Oct; 35(10):891-6. PubMed ID: 25339324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts-a paired sample study.
    Talwadekar MD; Kale VP; Limaye LS
    Sci Rep; 2015 Oct; 5():15784. PubMed ID: 26507009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Bone Marrow Mesenchymal Stem Cells Promote Gastric Cancer Growth via Regulating
    Chen B; Yu J; Wang Q; Zhao Y; Sun L; Xu C; Zhao X; Shen B; Wang M; Xu W; Zhu W
    Stem Cells Int; 2018; 2018():9501747. PubMed ID: 30186330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming Equine Bone Marrow-Derived Mesenchymal Stem Cells with Proinflammatory Cytokines: Implications in Immunomodulation-Immunogenicity Balance, Cell Viability, and Differentiation Potential.
    Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Gosálvez J; Roy R; Zaragoza P; Martín-Burriel I; Rodellar C
    Stem Cells Dev; 2017 Jan; 26(1):15-24. PubMed ID: 27712399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Culture medium of bone marrow-derived human mesenchymal stem cells effects lymphatic endothelial cells and tumor lymph vessel formation.
    Zhan J; Li Y; Yu J; Zhao Y; Cao W; Ma J; Sun X; Sun L; Qian H; Zhu W; Xu W
    Oncol Lett; 2015 Mar; 9(3):1221-1226. PubMed ID: 25663886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.